Dana­her ex­pects about $350M in tar­iff costs; Alu­mis, Ace­lyrin ad­just deal terms

Plus, news about In­vivyd:

Dana­her’s tar­iffs hit: The life sci­ences com­pa­ny cur­rent­ly ex­pects the costs of tar­iffs to be “some­thing like $350 mil­lion” in 2025 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER